Primecap Management
SPPI

Primecap Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Primecap Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-460,000
Closed -$1.55M – 314
2020
Q2 		$1.55M Hold
460,000
– – ﹤0.01% 282
2020
Q1 		$1.07M Sell
460,000
-5,956,000
-93% -$16.3M ﹤0.01% 276
2019
Q4 		$23.4M Sell
6,416,000
-4,559,800
-42% -$36.8M 0.02% 205
2019
Q3 		$91M Sell
10,975,800
-150,200
-1% -$1.21M 0.07% 144
2019
Q2 		$95.8M Buy
11,126,000
+67,000
+0.6% +$599K 0.07% 148
2019
Q1 		$118M Buy
11,059,000
+25,270
+0.2% +$271K 0.09% 139
2018
Q4 		$96.5M Sell
11,033,730
-126,270
-1% -$1.61M 0.08% 139
2018
Q3 		$187M Buy
11,160,000
+1,034,000
+10% +$22.4M 0.13% 120
2018
Q2 		$212M Buy
10,126,000
+2,706,000
+36% +$50.1M 0.16% 114
2018
Q1 		$119M Buy
7,420,000
+2,854,000
+63% +$56.5M 0.09% 138
2017
Q4 		$86.5M Buy
4,566,000
+560,000
+14% +$10.1M 0.07% 151
2017
Q3 		$56.4M Buy
+4,006,000
New +$36.2M 0.05% 170

Other funds holding SPPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Primecap Management's SPPI Position: Q3 2020 in Review

Primecap Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 460,000 shares — an estimated $1.55M sold.

Primecap Management first reported a position in SPPI in Q3 2017 and held it in 12 quarters. The position peaked at $212M in Q2 2018. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

  • Primecap Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Primecap Management sold 460,000 Spectrum Pharmaceuticals Inc shares in Q3 2020, an estimated $1.55M.
  • Primecap Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and held it in 12 quarters.
  • Primecap Management's Spectrum Pharmaceuticals Inc position peaked at $212M in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on Primecap Management's 13F filing for Q3 2020, filed 13 Nov 2020.